Literature DB >> 1372585

Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.

S Yajima1, Y Suzuki, N Shimozawa, S Yamaguchi, T Orii, Y Fujiki, T Osumi, T Hashimoto, H W Moser.   

Abstract

Genetic heterogeneity in peroxisome-deficient disorders, including Zellweger's cerebrohepatorenal syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease, was investigated. Fibroblasts from 17 patients were fused using polyethylene glycol, cultivated on cover slips, and the formation of peroxisomes in the fused cells was visualized by immunofluorescence staining, using anti-human catalase IgG. Two distinct staining patterns were observed: (1) peroxisomes appeared in the majority of multinucleated cells, and (2) practically no peroxisomes were identified. Single step 12-(1'-pyrene) dodecanoic acid/ultraviolet (P12/UV)-selection confirmed that the former groups were resistant to this selection, most of the surviving cells contained abundant peroxisomes, and the latter cells died. In the complementary matching, [1-14C]lignoceric acid oxidation and the biosynthesis of peroxisomal proteins were also normalized. Five complementation groups were identified. Group A: Zellweger syndrome and infantile Refsum disease; Groups B, C and D: Zellweger syndrome; Group E: Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease. We compared these groupings with those of Roscher and identified eight complementation groups. There was no obvious relation between complementation groups and clinical phenotypes. These results indicate that the transport, intracellular processing and function of peroxisomal proteins were normalized in the complementary matching and that at least eight different genes are involved in the formation of normal peroxisomes and in the transport of peroxisomal enzymes.

Entities:  

Mesh:

Year:  1992        PMID: 1372585     DOI: 10.1007/bf00219334

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Peroxisomal membrane ghosts in Zellweger syndrome--aberrant organelle assembly.

Authors:  M J Santos; T Imanaka; H Shio; G M Small; P B Lazarow
Journal:  Science       Date:  1988-03-25       Impact factor: 47.728

3.  Synthesis of a major integral membrane polypeptide of rat liver peroxisomes on free polysomes.

Authors:  Y Fujiki; R A Rachubinski; P B Lazarow
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Zellweger-like syndrome with detectable hepatic peroxisomes: a variant form of peroxisomal disorder.

Authors:  Y Suzuki; N Shimozawa; T Orii; N Igarashi; N Kono; A Matsui; Y Inoue; S Yokota; T Hashimoto
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

5.  A prenatal test for the cerebro-hepato-renal (Zellweger) syndrome by demonstration of the absence of catalase-containing particles (peroxisomes) in cultured amniotic fluid cells.

Authors:  R J Wanders; G Schrakamp; H van den Bosch; J M Tager; R B Schutgens
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

6.  Deficient activities and proteins of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome.

Authors:  Y Suzuki; T Orii; M Mori; M Tatibana; T Hashimoto
Journal:  Clin Chim Acta       Date:  1986-04-30       Impact factor: 3.786

7.  Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.

Authors:  N S Datta; G N Wilson; A K Hajra
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

8.  Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.

Authors:  W W Chen; P A Watkins; T Osumi; T Hashimoto; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts.

Authors:  E A Wiemer; S Brul; W W Just; R Van Driel; E Brouwer-Kelder; M Van Den Berg; P J Weijers; R B Schutgens; H Van Den Bosch; A Schram
Journal:  Eur J Cell Biol       Date:  1989-12       Impact factor: 4.492

10.  Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorder.

Authors:  Y Suzuki; N Shimozawa; T Orii; N Igarashi; N Kono; T Hashimoto
Journal:  Clin Chim Acta       Date:  1988-02-29       Impact factor: 3.786

View more
  23 in total

1.  Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency).

Authors:  R J Wanders; P A Mooijer; C Dekker; Y Suzuki; N Shimozawa
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C.

Authors:  Avraham Zeharia; Merel S Ebberink; Ronald J A Wanders; Hans R Waterham; Alisa Gutman; Andreea Nissenkorn; Stanley H Korman
Journal:  J Hum Genet       Date:  2007-05-30       Impact factor: 3.172

3.  Absence of mutations raises doubts about the role of the 70-kD peroxisomal membrane protein in Zellweger syndrome.

Authors:  B C Paton; S E Heron; P V Nelson; C P Morris; A Poulos
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 4.  Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders.

Authors:  Y Suzuki; N Shimozawa; A Imamura; S Fukuda; Z Zhang; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

5.  Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.

Authors:  N Shimozawa; Y Suzuki; T Orii; A Moser; H W Moser; R J Wanders
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

6.  Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis.

Authors:  T Tsukamoto; N Shimozawa; Y Fujiki
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 7.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis.

Authors:  Y Suzuki; N Shimozawa; S Yajima; S Tomatsu; N Kondo; Y Nakada; S Akaboshi; M Lai; Y Tanabe; T Hashimoto
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

9.  Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders.

Authors:  M Wendland; S Subramani
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.

Authors:  M Honsho; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.